Literature DB >> 23587696

Symptom dimensions and functional impairment in early psychosis: more to the story than just negative symptoms.

Daniel Fulford1, Tara A Niendam2, Erin G Floyd2, Cameron S Carter2, Daniel H Mathalon3, Sophia Vinogradov3, Barbara K Stuart4, Rachel L Loewy4.   

Abstract

Functional impairment is a defining feature of psychotic disorders and usually appears well before their onset. Negative symptoms play a prominent role in the impaired functioning of individuals with schizophrenia and those at clinical-high-risk (CHR) for psychosis. Despite high rates of depression and anxiety in early psychosis, few studies have examined the contribution of these symptoms to functioning in the putative 'prodrome.' In the current study, we tested the hypotheses that 1) worse negative and disorganized, but not positive, symptoms would be significantly related to impaired social and role functioning in two cohorts of CHR individuals (combined N=98) and a separate sample of individuals with recent-onset (RO) psychotic disorders (N=88); and 2) worse anxiety and depression would be significantly related to impaired functioning in both samples, above and beyond the contributions of negative and disorganized symptoms. Findings largely supported our hypotheses that more severe negative and disorganized symptoms were related to poorer social and role functioning in both samples. Anxiety and depression severity were significantly related to poorer functioning in both samples. In addition, depression, but not anxiety, predicted poorer global and social functioning above and beyond that explained by negative symptoms in the CHR sample. These results suggest the need for phase-specific treatment in early psychosis, with a focus on symptom dimensions to improve functional outcomes for CHR individuals.
Copyright © 2013 Elsevier B.V. All rights reserved.

Entities:  

Mesh:

Year:  2013        PMID: 23587696      PMCID: PMC3663589          DOI: 10.1016/j.schres.2013.03.024

Source DB:  PubMed          Journal:  Schizophr Res        ISSN: 0920-9964            Impact factor:   4.939


  55 in total

Review 1.  Quality of life in schizophrenia: a review of the literature from 1995 to 2000.

Authors:  Jaya Pinikahana; Brenda Happell; Judy Hope; Nicholas A Keks
Journal:  Int J Ment Health Nurs       Date:  2002-06       Impact factor: 3.503

2.  Reliability and validity of a depression rating scale for schizophrenics.

Authors:  D Addington; J Addington; E Maticka-Tyndale; J Joyce
Journal:  Schizophr Res       Date:  1992-03       Impact factor: 4.939

3.  The prediction of outcome in schizophrenia. I. Characteristics of outcome.

Authors:  J S Strauss; W T Carpenter
Journal:  Arch Gen Psychiatry       Date:  1972-12

4.  Association between psychotic experiences and depression in a clinical sample over 6 months.

Authors:  Alison R Yung; Joe A Buckby; Elizabeth M Cosgrave; Eoin J Killackey; Kathryn Baker; Sue M Cotton; Patrick D McGorry
Journal:  Schizophr Res       Date:  2007-01-18       Impact factor: 4.939

5.  Cognitive therapy for the prevention of psychosis in people at ultra-high risk: randomised controlled trial.

Authors:  Anthony P Morrison; Paul French; Lara Walford; Shôn W Lewis; Aoiffe Kilcommons; Joanne Green; Sophie Parker; Richard P Bentall
Journal:  Br J Psychiatry       Date:  2004-10       Impact factor: 9.319

6.  The symptoms of chronic schizophrenia. A re-examination of the positive-negative dichotomy.

Authors:  P F Liddle
Journal:  Br J Psychiatry       Date:  1987-08       Impact factor: 9.319

7.  Context-processing deficits in schizophrenia: diagnostic specificity, 4-week course, and relationships to clinical symptoms.

Authors:  Deanna M Barch; Cameron S Carter; Angus W MacDonald; Todd S Braver; Jonathan D Cohen
Journal:  J Abnorm Psychol       Date:  2003-02

8.  Prolonged untreated illness duration from prodromal onset predicts outcome in first episode psychoses.

Authors:  Matcheri S Keshavan; Gretchen Haas; Jean Miewald; Debra M Montrose; Ravinder Reddy; Nina R Schooler; John A Sweeney
Journal:  Schizophr Bull       Date:  2003       Impact factor: 9.306

9.  Risk factors for psychosis in an ultra high-risk group: psychopathology and clinical features.

Authors:  Alison R Yung; Lisa J Phillips; Hok Pan Yuen; Patrick D McGorry
Journal:  Schizophr Res       Date:  2004-04-01       Impact factor: 4.939

Review 10.  Anxiety disorders and schizophrenia.

Authors:  Jacqueline E Muller; Liezl Koen; Seedat Soraya; Robin A Emsley; Daniel J Stein
Journal:  Curr Psychiatry Rep       Date:  2004-08       Impact factor: 8.081

View more
  32 in total

1.  Factor Analysis of Negative Symptom Items in the Structured Interview for Prodromal Syndromes.

Authors:  Matilda Azis; Gregory P Strauss; Elaine Walker; William Revelle; Richard Zinbarg; Vijay Mittal
Journal:  Schizophr Bull       Date:  2019-09-11       Impact factor: 9.306

2.  Interpersonal sensitivity and functioning impairment in youth at ultra-high risk for psychosis.

Authors:  A Masillo; L R Valmaggia; R Saba; M Brandizzi; J F Lindau; A Solfanelli; M Curto; F Narilli; L Telesforo; G D Kotzalidis; D Di Pietro; M D'Alema; P Girardi; P Fiori Nastro
Journal:  Eur Child Adolesc Psychiatry       Date:  2015-02-25       Impact factor: 4.785

3.  Social motivation in people with recent-onset schizophrenia spectrum disorders.

Authors:  Timothy R Campellone; Brandy Truong; David Gard; Danielle A Schlosser
Journal:  J Psychiatr Res       Date:  2018-01-12       Impact factor: 4.791

4.  Converting positive and negative symptom scores between PANSS and SAPS/SANS.

Authors:  Theo G M van Erp; Adrian Preda; Dana Nguyen; Lawrence Faziola; Jessica Turner; Juan Bustillo; Aysenil Belger; Kelvin O Lim; Sarah McEwen; James Voyvodic; Daniel H Mathalon; Judith Ford; Steven G Potkin
Journal:  Schizophr Res       Date:  2013-12-11       Impact factor: 4.939

5.  Olfactory performance segregates effects of anhedonia and anxiety on social function in patients with schizophrenia.

Authors:  Kristina Cieslak; Julie Walsh-Messinger; Arielle Stanford; Leila Vaez-Azizi; Daniel Antonius; Jill Harkavy-Friedman; Deborah Goetz; Raymond R Goetz; Dolores Malaspina
Journal:  J Psychiatry Neurosci       Date:  2015-11       Impact factor: 6.186

6.  Symptom assessment in early psychosis: the use of well-established rating scales in clinical high-risk and recent-onset populations.

Authors:  Daniel Fulford; Rahel Pearson; Barbara K Stuart; Melissa Fisher; Daniel H Mathalon; Sophia Vinogradov; Rachel L Loewy
Journal:  Psychiatry Res       Date:  2014-08-01       Impact factor: 3.222

7.  Factor analysis of the Scale of Prodromal Symptoms: data from the Early Detection and Intervention for the Prevention of Psychosis Program.

Authors:  Ivy F Tso; Stephan F Taylor; Tyler B Grove; Tara Niendam; Steven Adelsheim; Andrea Auther; Barbara Cornblatt; Cameron S Carter; Roderick Calkins; J Daniel Ragland; Tamara Sale; William R McFarlane
Journal:  Early Interv Psychiatry       Date:  2014-12-21       Impact factor: 2.732

8.  Reliability and validity of the Calgary Depression Scale for Schizophrenia (CDSS) in youth at clinical high risk for psychosis.

Authors:  Jean Addington; Hely Shah; Lu Liu; Donald Addington
Journal:  Schizophr Res       Date:  2014-01-16       Impact factor: 4.939

9.  Involvement in mental health self-help groups and recovery.

Authors:  Fred E Markowitz
Journal:  Health Sociol Rev       Date:  2015-03-30

10.  Schizophrenia symptom and functional correlates of anterior cingulate cortex activation to emotion stimuli: An fMRI investigation.

Authors:  Brady D Nelson; Olivia A Bjorkquist; Emily K Olsen; Ellen S Herbener
Journal:  Psychiatry Res       Date:  2015-11-06       Impact factor: 3.222

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.